SCHEMBL7190020

SCHEMBL7190020

C=CCCCCCCCCC(=O)NCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.37

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA12 known ✓ O43570 1/20 0.32
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.37
LPAR1 Q92633 2/20 0.34
LPAR2 Q9HBW0 2/20 0.34
ENPP2 Q13822 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
EPHX2 P34913 2/20 0.32
ABCC4 O15439 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CA9 Q16790 1/20 0.32
GAA P10253 1/20 0.32
CNR1 P21554 2/20 0.31
CNR2 P34972 1/20 0.31
FAAH O00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415397 0.86 LPAR1 (0.51) ALDH1A1LPAR1LPAR2ENPP2TRPV1
SCHEMBL28040905 0.84 ALDH1A1 (0.40) ALDH1A1LMNALPAR1LPAR2ENPP2
SCHEMBL2727565 0.77 FAAH (0.43) ALDH1A1LPAR1LPAR2ENPP2CNR1
SCHEMBL28040906 0.75 ABCC4 (0.41) ALDH1A1LMNALPAR1LPAR2ENPP2
SCHEMBL29392097 0.72 LPAR1 (0.52) ALDH1A1LPAR1LPAR2ENPP2TRPV1
SCHEMBL14972390 0.72 ALDH1A1 (0.54) ALDH1A1LMNALPAR1LPAR2ENPP2
Disodium Lauramido Mea SCHEMBL3697471 0.70 FAAH (0.43) ALDH1A1LPAR1LPAR2ENPP2EPHX2
SCHEMBL5364934 0.69 ALDH1A1 (0.66) ALDH1A1LMNATRPV1EPHX2ABCC4
SCHEMBL2687424 0.69 EPHX2 (0.45) ALDH1A1LPAR1TRPV1EPHX2MAPT
SCHEMBL2727705 0.69 RECQL (0.46) ALDH1A1LPAR1LPAR2ENPP2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106948-A1 FIRE RETARDANT COMPOSITIONS CONTAINING ONE OR MORE SURFACTANTS PERIMETER SOLUTIONS LP (US) 2026-05-21 WO claimed
EP-3664769-B1 HIGH OIL-CONTENT FOAMING EMULSION AND USES THEREOF, IN PARTICULAR FOR PERSONAL HYGIENE LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) 2023-07-26 EP claimed
WO-2026106948-A1 FIRE RETARDANT COMPOSITIONS CONTAINING ONE OR MORE SURFACTANTS PERIMETER SOLUTIONS LP (US) 2026-05-21 WO disclosed
EP-4743050-A1 3-HYDROXYPROPYLESTERS AS FOAM AND VISCOSITY MODULATING AGENTS IN SURFACTANT CONTAINING FORMULATIONS Symrise AG (DE) 2026-05-20 EP disclosed
WO-2026087745-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-30 WO disclosed
EP-4732825-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-29 EP disclosed
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS SYMRISE AG (DE) 2026-04-09 US disclosed
EP-4186969-B1 SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION HENKEL AG & CO KGAA (DE) 2026-04-01 EP disclosed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP disclosed
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 US disclosed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US disclosed
WO-2020131080-A1 HOME CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2020-06-25 WO disclosed
CN-1167411-C Skin cleaning method for eliminating comedones and scales from parts of skin subjected to proliferation of i(candida Alibicans) 策卡有限公司 2004-09-22 CN disclosed
EP-0947192-B1 Transparent antidandruff shampoos CECA SA (FR) 2003-11-26 EP disclosed
CN-1356891-A Skin cleaning method for eliminating comedones and scales from parts of skin subjected to proliferation of i(candida Alibicans) CECA SA (FR) 2002-07-03 CN disclosed
US-6410593-B1 MIXTURE OF ANIONIC SURFACTANT, AMPHOTERIC SURFACTANT AND FUNGICIDES CECA S.A. (FR) 2002-06-25 US disclosed
EP-1171095-A1 SKIN CLEANING METHOD FOR ELIMINATING COMEDONES AND SCALES FROM PARTS OF THE SKIN SUBJECTED TO THE PROLIFERATION OF (CANDIDA ALBICANS) CECA S.A. (FR) 2002-01-16 EP disclosed
WO-2000062756-A1 SKIN CLEANING METHOD FOR ELIMINATING COMEDONES AND SCALES FROM PARTS OF THE SKIN SUBJECTED TO THE PROLIFERATION OF $i(CANDIDA ALBICANS) CECA S.A. (FR) 2000-10-26 WO disclosed
EP-0947192-A1 Transparent antidandruff shampoos CECA S.A. (FR) 1999-10-06 EP disclosed
CN-1229637-A Transparent antidandruff shampoos CECA SA (FR) 1999-09-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 CA12 4850/4885ALDH1A1 4611/4885LMNA 4342/4885
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL RBP4, LRAT, RARB CA12 433/4885ALDH1A1 156/4885LMNA 2563/4885
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS PTGS2, PTGES2, PTGS1 CA12 754/4885ALDH1A1 705/4885LMNA 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.